Literature DB >> 20477425

Cellular and hormonal content of breast nipple aspirate fluid in relation to the risk of breast cancer.

Seema A Khan1, Robert T Chatterton.   

Abstract

In research settings, the measurement of serum and urine hormone concentrations has shown modest positive relationships with breast cancer risk in postmenopausal women. However, the local production of sex steroids in the breast is a significant contributor to the hormonal environment of the breast. Nipple aspiration fluid provides a window into this environment and allows the measurement of hormone and protein content which may show stronger relations to breast cancer risk, and therefore enable both more accurate risk assessment, and the use of preventive measures directed to the lowering of local breast hormonal exposure.

Entities:  

Year:  2008        PMID: 20477425     DOI: 10.2217/17520363.2.5.479

Source DB:  PubMed          Journal:  Biomark Med        ISSN: 1752-0363            Impact factor:   2.851


  3 in total

1.  The physiology of the normal human breast: an exploratory study.

Authors:  Dixie Mills; Eva J Gordon; Ashley Casano; Sarah Michelle Lahti; Tinh Nguyen; Alex Preston; Julie Tondre; Kuan Wu; Tiffany Yanase; Henry Chan; David Chia; Mahtash Esfandiari; Tiffany Himmel; Susan M Love
Journal:  J Physiol Biochem       Date:  2011-10-08       Impact factor: 4.158

Review 2.  Nipple aspirate fluid and its use for the early detection of breast cancer.

Authors:  Natasha Jiwa; Ahmed Ezzat; Josephine Holt; Dhuleep S Wijayatilake; Zoltan Takats; Daniel Richard Leff
Journal:  Ann Med Surg (Lond)       Date:  2022-04-18

3.  Hormonal determinants of nipple aspirate fluid yield among breast cancer cases and screening controls.

Authors:  Angela J Fought; Claire McGathey; Denise M Scholtens; Richard E Heinz; Rick Lowe; Yvonne B Feeney; Oukseub Lee; Thomas E Kmiecik; Judith A Wolfman; Charles V Clevenger; Peter H Gann; Susan Gapstur; Robert T Chatterton; Seema A Khan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-09-18       Impact factor: 4.254

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.